A phase Ib study of cancer stem cell (CSC) pathway inhibitor BBI-608 in combination with gemcitabine and nab-paclitaxel (nab-PTX) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC)
Shahda, Safi⋅El-Rayes, Bassel F⋅O'Neil, Bert H⋅Starodub, Alexander⋅Hanna, Wahid Tewfik⋅Borodyansky, Laura⋅Oh, Cindy⋅Li, Chiang and Bekaii-Saab, Tanios S
Journal of Clinical Oncology, vol. 34, (no. 4_suppl), pp. 284, 2016-02-01. | Journal Article